Table 4.

Relative risk of clinical outcomes (a second PTCA, myocardial infarction, CABG, cardiovascular death) according to LIPC gene genotypes

LIPC status	CAD subjects with clinical outcomes	CAD subjects without clinical outcomes
	n. (%)	n. (%)	Odds ratio (95% CI)
CC (wild type) carriers	6 (13.4%)	9 (60%)	1
GG + GC carriers	39 (86.6%)	6 (40%)	7.6 (1.01–57.2)*

Odds ratios were adjusted for age, sex, plasma triglycerides, LDL-cholesterol, HDL-cholesterol, smoking habits (yes/no). Triglycerides were also independent predictors of clinical outcomes (OR 1.01 (95% CI: 1.00–1.02), p < 0.04) * p < 0.03